DuoCort AB: DuoCort announces Phase I Data Presentation at the European Congress of Endocrinology
HELSINGBORG, Sweden--(BUSINESS WIRE)--Apr 25, 2007 - DuoCort AB today announced that results of the Phase I trial of its 5 mg and 20 mg dual release hydrocortisone tablets for adrenal insufficiency will be presented at the 9th European Congress of Endocrinology on April 30 in Budapest. The trial ev...DuoCort: New chronotherapy for adrenal insufficiency
...ingborg Sweden June 29th 2009 / b3c newswire / - duocort publishes data from its Phase I study for the rare...the natural secretion pattern of cortisol. The new duocort therapy showed no absorption failure allowing it t... variation in serum cortisol that normally occurs. duocort seeks to do so by providing a so-called chronother...DuoCort Survey - Library - Article | Pituitary Network Association
Translated content for this page: Spanish French. DuoCort Survey ... This survey will provide DuoCort with essential feedback to help in the ...DuoCort: New Chronotherapy For Adrenal Insufficiency
DuoCort publishes data from its Phase I study for the rare and life threatening ... The new DuoCort therapy showed no absorption failure allowing it to be safely ...News: DuoCort AB: DuoCort announces Phase I Data Presentation at the ...
DuoCort AB today announced that results of the Phase I trial of its 5 mg and 20 mg dual release hydrocortisone tablets for adrenal insufficiency will be presented at ...